Study finds cough drugs no better than sugar syrup

Key points
- Two ingredients commonly used in cough syrup are no better than sugar water in suppressing night-time coughing in children, according to a study published on Tuesday.
- The two ingredients are dextromethorphan - often listed on labels as "DM" - and diphenhydramine, an antihistamine.
- "Consumers spend billions of dollars each year on over-the-counter medications for cough," said Ian Paul, a physician and assistant professor of pediatrics at Penn State Children's Hospital.
- "Our study showed that the two ingredients used in most over-the-counter medications were no better than a placebo ... in providing night time relief for children with cough and sleep difficulty as a result of upper respiratory infection," he added.
Two ingredients commonly used in cough syrup are no better than sugar water in suppressing night-time coughing in children, according to a study published on Tuesday.
The two ingredients are dextromethorphan - often listed on labels as "DM" - and diphenhydramine, an antihistamine. The former is the most common nonprescription cough suppressant on the U.S. market, and commonly abused by adolescents who try to get high on cough medicine.
"Consumers spend billions of dollars each year on over-the-counter medications for cough," said Ian Paul, a physician and assistant professor of pediatrics at Penn State Children's Hospital.
"Our study showed that the two ingredients used in most over-the-counter medications were no better than a placebo ... in providing night time relief for children with cough and sleep difficulty as a result of upper respiratory infection," he added.
Paul was the chief author of the study appearing in the July issue of Pediatrics, the journal of the American Academy of Pediatrics.
The findings were based on 100 children aged 2 to 18 with upper respiratory infections. Their parents were quizzed about the severity of the children's cough and how well both parents and children slept the previous night.
In the evening of the day the parents were questioned the children were given either one of the commercial preparations or an inert placebo - in this case simple syrup.
"There was a significant improvement for all symptoms over the previous night, which should reassure clinicians and parents that, regardless of treatment, the natural history of an upper respiratory infection favors resolution of symptoms with time," Paul said.
In an interview, Paul said the improvement in symptoms across-the-board was due to both the natural progression of an infection easing one day to the next and the well-documented "placebo effect," where symptoms diminish because a patient believes a treatment is helping.
He said the sleep of both parents and children improved but the improvement was the same in the group given sugar syrup as for the children given the drugs.
Asked what parents should do, Paul said "my advice has been to do things that are harmless but could help - saline nose drops, good hydration and humidified air."
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Lungs, Asthma & Allergies →
NewsEffective Test to Determine Treatment for Chronic Cough
Mayo Clinic researchers have found that an asthma diagnostic test, the exhaled nitric oxide test, is an inexpensive, quick and easy way to determine whether inhaled corticosteroids will relieve a patient's chronic…
7 September 2006
NewsNew View of Asthma May Offer a Better Treatment Target
A newly recognized type of immune cell may play an important role in causing asthma, perhaps explaining why current therapies sometimes fail, report researchers from Children's Hospital Boston in the March 16th New…
17 March 2006
NewsNew molecular target for potential drugs to treat acute respiratory distress syndrome
Researchers at the University of Virginia Health System have identified a molecular target, or receptor, for potential drugs to treat acute respiratory distress syndrome (ARDS), a sudden and life-threatening failure of…
